Latest news
Experimental Drug Turns Cancer’s Favorite Fuel — Sugar — Against It - news.utexas.edunews.utexas.edu · Wed, 05 Aug 2026 21:42:35 GMTEli Lilly’s Obesity Drugs Drive Massive Revenue Growth - ForbesForbes · Wed, 05 Aug 2026 21:00:36 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTLLY Q2 Earnings Top, GLP-1 Drugs Fuel Growth, Sales Guidance Raised - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 16:07:00 GMTEli Lilly’s obesity drugs fuel revenue growth as demand shows no sign of slowing down - RSM UKRSM UK · Tue, 04 Aug 2026 07:00:00 GMTUCB Earnings: Growth Products Fuel Revenue Expansion Amid Declining Sales for Legacy Drugs - MorningstarMorningstar · Sat, 01 Aug 2026 01:36:23 GMTNo-Moat UCB's Growth Products Fuel Revenue Expansion Amid Declining Sales for Legacy Drugs - MorningstarMorningstar · Fri, 31 Jul 2026 19:01:05 GMTSun Pharma banks on specialty drug portfolio, India business to drive growth in FY27 - Moneycontrol.comMoneycontrol.com · Fri, 31 Jul 2026 07:00:00 GMT